Enliven Therapeutics, Inc. (ELVN)
(Delayed Data from NSDQ)
$27.31 USD
+2.29 (9.15%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $27.24 -0.07 (-0.26%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.58 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | 6.90% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.26 |
Next Year | -2.74 |
EPS (TTM) | -1.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 0.50M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 0.50M |
Low Estimate | NA | NA | NA | 0.50M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.58 | -0.62 | -2.26 | -2.74 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.51 | -0.56 | -2.19 | -2.73 |
High Estimate | -0.51 | -0.56 | -2.19 | -2.73 |
Low Estimate | -0.65 | -0.68 | -2.33 | -2.75 |
Year ago EPS | -0.41 | -0.51 | -2.01 | -2.26 |
Year over Year Growth Est. | -41.46% | -21.57% | -12.44% | -21.24% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.58 | -0.62 | -2.26 | -2.74 |
7 Days Ago | -0.58 | -0.62 | -2.26 | -2.74 |
30 Days Ago | -0.58 | -0.62 | -2.26 | -2.74 |
60 Days Ago | -0.58 | -0.62 | -2.26 | -2.74 |
90 Days Ago | -0.61 | -0.64 | -2.16 | -2.81 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.58 | -0.62 | -2.26 | -2.74 |
Zacks Consensus Estimate | -0.58 | -0.62 | -2.26 | -2.74 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.54 | -0.47 | -0.51 | -0.41 | NA |
Estimate | -0.58 | -0.56 | -0.49 | -0.40 | NA |
Difference | 0.04 | 0.09 | -0.02 | -0.01 | 0.03 |
Surprise | 6.90% | 16.07% | -4.08% | -2.50% | 4.10% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more